Molecular carcinogenesis of squamous cell carcinomas of the skin by Kubo, Yoshiaki et al.
INTRODUCTION
Squamous cell carcinomas (SCCs) of the skin are
one of the most common skin cancers associated
with a substantial risk of metastasis (1). It is wide-
ly accepted that normal keratinocytes in the epider-
mis can convert to SCCs through a multistep pro-
cess that involves activation of proto-oncogenes
and/or inactivation of tumor suppressor genes (2, 3).
In this study, we review the molecular carcinogenesis
of SCCs.
CAUSATION
Exposure to ultra-violet (UV) radiation is the most
common cause of skin cancers (4, 5). In particular,
UV-B radiation is mainly involved in the mutagenesis in
the skin by two major photoproducts of a cyclobutane
pyrimidine dimer and (6-4) photoproducts (6, 7). After
UV-B radiation exposure, DNA damage in the keratinocytes
would usually be repaired properly by means of
DNA base excision repair. However, the abnormalities
of genes would remain in the cells, if the cells fail
to undergo DNA damage repair they could escape
from apoptosis. Recently, tanning devices have been
reported to be associated with odds ratios of 2.5
for SCCs in Caucasians (8).
The hypercarcinogenic state has been defined as the
state that cells are susceptible to the occurrence and
accumulation of gene mutations (9). Hypercarcinogenic
REVIEW
Molecular carcinogenesis of squamous cell carcinomas
of the skin
Yoshiaki Kubo1, Kazutoshi Murao1, Kazuya Matsumoto2, and Seiji Arase1
1Department of Dermatology, and 2Department of Plastic and Reconstructive Surgery,
The University of Tokushima School of Medicine, Tokushima, Japan
Abstract : Squamous cell carcinomas (SCCs) of the skin were suggested to develop through
a multistep process that involves activation of proto-oncogenes and/or inactivation of tumor
suppressor genes in the human skin keratinocytes. Exposure to ultra-violet (UV), especial-
ly UV-B, radiation is the most common cause for these genetic abnormalities in cells. We re-
view causation of SCCs and genetic abnormalities in human SCCs with the current work.
To elucidate the multistep process, we developed a method for examining the combinatorial
function in vivo of plural genes in human keratinocytes. Using high efficiency retroviral
transductions, we could express plural genes serially in normal human primary keratinocytes
and use these cells to regenerate human skin on SCID mice. A combinatorial transduction
of H-RasV12 and cyclin dependent kinase 4 (CDK4) produced human epidermal neoplasia
resembling SCC. These findings were consistent with our previous results of mutation analy-
sis in SCCs, one of which had both mutations of H-Ras gene and the INK4a locus. There-
fore, it is suggested that a combination of these genetic abnormalities might be crucial to
the carcinogenesis at least in a subset of SCCs. J. Med. Invest. 49 : 111-117, 2002
Keywords : squamous cell carcinomas (SCCs), skin cancer, ultra-violet (UV) radiation, gene mutation,
keratinocyte
Received for publication June 7, 2002 ; accepted June 20,
2002.
Address correspondence and reprint requests to Yoshiaki
Kubo, M.D., Department of Dermatology, The University of
Tokushima School of Medicine, Kuramoto-cho, Tokushima 770-8503,
Japan and Fax : +81-88-632-0434.
The Journal of Medical Investigation Vol. 49 2002
１１１
states for SCCs consist of inherited lesions, e.g.,
xeroderma pigmentosum that is defective in DNA
base excision repair, and the acquired lesions, e.g.,
chronic ulcers, burn and posttraumatic scars, and
Discoid lupus erythematosus. Among them, each of
the candidate genes for all types of xeroderma
pigmentosum has previously been identified, and
the mechanism of DNA base excision repair has been
elucidated (10). Although how gene mutations ac-
cumulate in the acquired lesions is poorly under-
stood, the continually accelerated turnover of the
cell cycle in chronic ulcers was suggested to be one
of the most important factors for the initiation, pro-
motion, and progression of carcinogenesis as the
hypercarcinogenic state (9).
SCCs occur with high frequency in renal allograft
recipients after prolonged immunosuppression (11).
Human papillomavirus (HPV) infections are likely to
be an important factor because they are often detect-
ed in these conditions (12, 13). In oncogenic types
of HPV 16 and 18, which are frequently detected in
uterocervical cancers, E6 protein inactivates the p53
tumor suppressor gene product and up-regulates
hTERT, the reverse transcriptase of telomerase, and
E7 protein inactivates Rb (Retinoblastoma) tumor
suppressor gene product (14). It may be uncertain
that HPV should mainly contribute to the develop-
ment of SCCs because HPV 16 or 18 are not often
detected in those on the immunosuppressive patients.
However, E6 proteins of other types of HPV detect-
ed frequently in the skin also target and abrogate
the function of Bak, an apoptosis-related protein that
is induced by UV (15). Thus, HPV may contribute to
the development of SCCs against apoptotic signals
in keratinocytes.
Some gene polymorphisms related to the suscep-
tibility of SCCs were reported in the general popu-
lation of Caucasians recently. Greater than twenty
polymorphisms were reported in the melanocortin-1
receptor (MC1-R), which has been associated with
physiologic variation in hair and skin color. In par-
ticular, the variants Arg151Cys and Arg160Trp were
strongly associated with fair skin and red hair, and
carriers of the two variant alleles were at increased
risk for developing SCCs (16). The DNA base ex-
cision repair gene XRCC1 Arg399Gln polymorphism
was also reported to be associated with the occur-
rence of SCCs (17). These associations between gene
polymorphisms and the occurrence of SCCs remain
uncertain in the general Japanese population.
GENETIC ABNORMALITIES
1) Chromosomal abnormalities
The majority of a number of DNA ploidy studies
reveal that aneuploidy is shown in some SCCs (18).
Consistent with these findings, clonal chromosomal
abnormalities have been reported in a subset of
SCCs, although it is technically difficult to perform
karyotypic analysis in solid tumors (19). Chromoso-
mal instabilities may be critical on the carcinogenesis
in a subset of SCCs, although chromosomal insta-
bilities as a result of transformation or technical ar-
tifacts could not be completely excluded.
2) Proto-oncogene Ras
Ras genes consist of three different genes, H-Ras ,
K-Ras, and N-Ras, and activating Ras mutations are
one of the most common genetic abnormalities in
various human cancers (20). The Ras proteins are
small G-proteins that transduce intracellular signal,
and are constitutively activated by point mutations
of codons 12, 13, and 61 of Ras genes (20, 21). Through
the activated Ras pathway, many tumor-promoting
effects, e.g., accelerating cell growth and inhibiting
apoptosis, are induced (21). Ras mutations have been
well characterized in the mouse skin two-stage
carcinogenesis model, because the mutations are fre-
quently detected after the initiation with the genotoxic
carcinogen dimethylbenzanthracene (DMBA) (22,
23). However, the rates of Ras mutations in human
SCCs vary between 0% and 46% (24, 25), and we also
detected Ras mutations in only one of 21 SCC cases
(Table 1) (26). Activating Ras mutations should be
important on the carcinogenesis in a subset of SCCs,
although the role of Ras activation in SCCs develop-
ment remains unclear.
3) Tumor suppressor gene p53
Mutations of the p53 gene have been found in ap-
proximately half the SCC cases in addition to vari-
ous other human cancers (27-29). UV light-induced
photoproducts at dipyrimidine sites should contrib-
ute to these mutations, because mutations of C to
T or CC to TT predominate in SCCs that originate
in the sunlight-exposed skin region (27-29). Known
as “guardian of the genome” (30), p53 is involved
in a number of important cellular control pathways,
including G1 growth arrest and apoptosis, especial-
ly in response to DNA damage. p53 induces p21 and
p53R2 for repairing DNA damage in the cells dur-
ing G1 growth arrest (31, 32), and induces Bax and
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p53AIP1 for rendering cells apoptotic if huge DNA
damage remains in the cells (33, 34). The cells where
the p53 functions are lost would render them resist-
ant to cell growth arrest and apoptosis, and they would
be susceptible to the occurrence and accumulation
of gene mutations in addition to accelerated cell growth.
Since mutations of the p53 gene have been found
in lesions of solar keratosis and apparently histologi-
cal normal skin (35-38), the mutations might occur
at an early stage in the development of SCCs.
4) The INK4a locus
The INK4a locus encodes two different tumor sup-
pressor gene products, p16INK4a and p14ARF (39, 40).
Each has its own promoter and exon 1, and shares
the same exon 2 with different reading frames from
each other (39, 40). p16INK4a is involved in the func-
tion of cell growth suppression of Rb by binding cyclin
dependent kinase 4/6 (CDK4/6) and inhibiting their
enzyme activities (41), and p14ARF is involved in the
function of cell growth arrest and apoptosis of p53
by binding MDM2 and stabilizing p53 (40). Muta-
tions of the INK4a locus have been reported in up
to 20% of SCCs (42, 43). They have so far been de-
tected in exon 2, which is common to both p16INK4a
and p14ARF (42, 43). Although expression of the cata-
lytic component of telomerase, hTERT, alone is suf-
ficient for immortalizing human fibroblasts, both
Rb/ p16INK4a inactivation and hTERT are required to
immortalize human ketatinocytes (44). These find-
ings suggest that Rb/ p 16INK4a inactivation might have
some relevance to the carcinogenesis in some of
SCCs
5) Allelic loss
Tumor suppressor genes have been revealed by
the study of hereditary human cancers (45). Although
these genes render carriers heterozygous and so ap-
pear in pedigrees, as dominantly inherited disorders,
they were suggested to be recessive in carcinogenesis
(45). “Knudson’s two-hit hypothesis” that inactiva-
tion of both maternal and paternal alleles should
be essential in carcinogenesis is widely accepted. In
many instances, one allele is mutated and another
allele is lost although there are exceptions. Allelic
loss can be detected in tumor tissues by means of
PCR assays based on microsatellite sequences, which
are widely dispersed throughout the genome and
usually highly informative. Although allelic loss in
SCCs has been found on many chromosomes, the
rates of allelic loss are relative high, in approximate-
ly 20% to 40% of SCCs, on 3p, 9p, 9q, 13q, 17p, and
17 q (46-48). The INK4a locus, Rb gene, and p53 gene
are located on 9p, 13q, and 17p, respectively. Re-
cently, the gene responsible for multiple self-healing
squamous epithelioma syndrome (Ferguson-Smith)
was mapped on 9q22, which is expected to be iden-
tified (49).
THE MULTI-STEP PROCESS IN CARCINOGENESIS
Although many studies regarding chromosomal
and genetic abnormalities in SCCs have been report-
ed, the multi-step process in carcinogenesis of SCCs
is still unclear. We have been trying to examine the
combinatorial function of activation of proto-oncogenes
and inactivation of tumor suppressor genes in nor-
mal human keratinocytes (Figure 1), especially ac-
tivation of H-Ras and inactivation of the INK4a locus,
because we found one SCC with both mutations of
these two genes (26). Since neither dominant nega-
Table 1. Summary of gene mutatios in 21 SCCs
Age
(Gender)
Predisposing
conditions
TNM H-Ras p53 p16INK4a p14ARF
76 (M)
93 (F)
79 (M)
73 (M)
93 (F)
63 (F)
Sun exposure
I
II
II
II
II
II
－
－
－
－
－
G13R, C→G
－
Y107X, C→G
G２４４S, C→T
Q３１７X, C→T
R２４９T, C→G
－
CC→T
－
－
－
－
２１bp
deletion
CC→T
－
－
－
－
２１bp
deletion
48 (F)
88 (F)
68 (M)
Scar
Scar
Radiation
dermatitis
III
II
II
－
－
－
Y234X, C→A
E326X, C→A
H178Q, H179Y
CC→AT
R80X, C→T
－
－
P94L, C→T
－
－
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tive mutant p16INK4a nor p14ARF in the INK4a locus
were found, activation of CDK4 and inactivation of
p53 were substituted for inactivation of p16INK4a and
p14ARF, respectively. Using high efficiency retroviral
transductions in normal human primary keratinocytes
(50), we expressed H-RasV12 (an activated mutant
H-Ras), CDK4, p53W248 (a dominant-negative mu-
tant p53), and hTERT either singly or in combina-
tion and used these cells to regenerate human skin
on SCID mice.
A combination of H-RasV12 and CDK4 produced
human skin tumors with histologic features of SCC
at 7 weeks after grafting, although a combination of
H-RasV12 and p53W248 showed no specific effects
compared with normal controls (Figure 2) (51). The
tumors derived from the cells where both H-RasV12
and CDK4 were transduced (Ras-CDK4 tumors), simi-
lar to human SCCs, expressed increased levels of
Cyclin D1 and VEGF. Cyclin D1 was necessary but
not sufficient for Ras-CDK4 tumors, because a com-
bination of Cyclin D1 and CDK4 failed to induce tu-
mors while an anti-sense Cyclin D 1 retrovector that
suppressed D1 tissue protein expression abolished
Ras-CDK4 tumors (51). In addition, CDK4 synergy
with H-RasV12 is dependent on intrinsic CDK4 kinase
function because the kinase-dead N158 CDK4 point
mutant failed to induce tumors when co-expressed
with H-RasV12 (51). These findings identify Ras and
CDK4 as capable of converting normal human epi-
dermal tissue into invasive neoplasia and suggest
that functional CDK4 and Cyclin D1 is necessary for
this process. Thus, it is suggested that a combina-
tion of Ras activation and Rb/ p16INK4a inactivation
might be crucial to the carcinogenesis at least in a
subset of SCCs.
CONCLUDING REMARKS
Squamous cell carcinomas (SCCs) of the skin are
one of the most common skin disorders, and some-
times recur or metastasize after surgical excision.
Advanced SCCs are often resistant to radiation treat-
ment and chemotherapy. We hope that molecular
carcinogenesis of SCCs of the skin would be eluci-
dated in the near future to establish some markers
for the prognosis of SCCs and a novel effective thera-
py for advanced SCCs.
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